Engril.com

Today's Stories Tomorrow's History

Medicine

Sounds great – HCA milestone for PharmaTimes Communications Awards

Accreditation recognises ‘continued professional development’ opportunities As part of the Healthcare Communications Association’s partnership with this year’s PharmaTimes Communications Awards, we can now confirm that the competition has been HCA CPD Accredited. HCA CPD Accreditation recognises and endorses quality ‘continued…

Glasgow scientists develop first bone marrow model to support human stem cells

LT-HSCs replenish blood cells after treatment for blood cancers, such as leukaemia Scientists from the University of Glasgow have developed the first bioengineered bone marrow model that supports human stem cells, which are crucial for bone marrow transplants and in…

Study finds pain gene affects success of chronic pain medicine in women

Chronic pelvic pain is a disabling condition that affects around one in four women worldwide A study led by the University of Edinburgh in collaboration with the University of Oxford has found that a pain gene carried by women with…

Study reveals new AI tool predicts recurrence of prostate cancer by a decade

The most commonly diagnosed cancer in men in the UK leads to over 12,000 annual deaths A study led by researchers from the Institute of Cancer Research (ICR) and the Royal Marden NHS Foundation Trust has revealed a new tool…

Cystic fibrosis drug improves outcomes in severe COVID-19 pneumonia

Genentech’s Pulmozyme could also treat other respiratory infections and conditions Researchers from University College London (UCL), UCL Hospital (UCLH) and the Francis Crick Institute have revealed that a common drug used to treat cystic fibrosis has been shown to improve…

US study reveals Co-STAR receptor cells show promise in treating cancers

The most globally prevalent cancers include breast, lung, bowel and prostate cancers Researchers from Johns Hopkins Kimmel Cancer Center and its Ludwig Center, along with the Lustgarten Laboratory and the Bloomberg-Kimmel Institute for Cancer Immunotherapy, have designed a novel type…

McMaster researchers develop way to make phages more accessible

The new technology can generate a target infection within 30 minutes to two hours Researchers from McMaster University, with support from experts at Université Laval, Canada, have developed a new way to make lifesaving bacteriophages (phages) easier to use, more…

Dr Rafiq Hasan – PharmaTimes

Exonate has appointed Dr Rafiq Hasan as Non-Executive Director. Exonate has announced the expansion of its Board with the appointment of Dr Rafiq Hasan as Non-Executive Director. Rafiq brings extensive expertise in ophthalmology, specifically within the diabetic eye disease sector, from his years in global…

Study finds Parkinson’s disease SLT more effective than one used in NHS

The progressive neurodegenerative condition affects around 153,000 people in the UK Researchers from the Universities of Nottingham and Birmingham have revealed that a new form of speech therapy was more effective than the speech and language therapy (SLT) currently used…

NIHR and Diabetes UK invest nearly £3m to prevent and treat diabetes distress

Almost 50% of adults living with type 1 diabetes experience high levels of diabetes distress The National Institute for Health and Care Research (NIHR) and Diabetes UK have partnered, investing nearly £3m, to develop research to treat and prevent type…